Research
OSCR
Oscar Health Stock Analysis: Buy or Sell? Valuation, Margins & Cash Flow
Oscar Health (OSCR) is rated Hold as rapid revenue growth and strong free cash flow are offset by uneven margins and meaningful debt. The stock…
Most Popular Research
EOSEHOLDJun 22, 2026Eos Energy Enterprises Stock Analysis: EOSE Cash Burn, Revenue Growth & Financing RiskEos Energy Enterprises (EOSE) earns a Sell rating as rapid Q1 revenue growth is offset by persistent cash…SOUNSELLJun 14, 2026SoundHound AI Stock Analysis: Valuation, Cash Burn, Margins & Customer RiskSoundHound AI (SOUN) is rated SELL as rapid revenue growth is offset by weak profitability and ongoing cash…CASYJun 22, 2026USDW Stock: Made in USA 10-K Analysis & Growth ThesisMade IN USA (USDW)'s Risk Factors section changed the most among 14 companies that filed 10-Ks on 22…BSXBUYJun 14, 2026Boston Scientific Stock Analysis: Valuation, Reimbursement Risk, Cash Flow & GrowthBoston Scientific (BSX) earns a Buy rating on double-digit revenue growth, expanding EBITDA, and improving free cash flow.…USACHOLDAug 5, 2026USA Compression Partners Stock Analysis (NYSE: USAC) | HoldUSA Compression Partners, LP (USAC) is rated Hold as its fixed-fee compression franchise supports steadier cash flow, but…ALTSELLAug 26, 2026Altimmune Stock Analysis: Buy or Sell? Valuation, Cash Burn & Phase 3Altimmune (ALT) is rated Sell as the stock already prices in Phase 3 success while the business remains…